Published in Br J Pharmacol on March 09, 2010
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry (2012) 1.43
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol (2011) 0.96
Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats. Front Behav Neurosci (2014) 0.83
Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects. Stem Cells Transl Med (2015) 0.80
Brain neurotoxic amyloid-beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets. Br J Pharmacol (2010) 0.79
Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment. J Geriatr Psychiatry Neurol (2015) 0.79
In vivo diffusion tensor imaging of amyloid-β-induced white matter damage in mice. J Alzheimers Dis (2014) 0.78
Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression? Am J Geriatr Psychiatry (2016) 0.77
Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids. Brain Sci (2016) 0.76
Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid. Mol Neurobiol (2016) 0.76
Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1. Front Neurosci (2015) 0.75
Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1. Front Pharmacol (2016) 0.75
Synthesis and Biological Evaluation of Novel Multi-target-Directed Benzazepines Against Excitotoxicity. Mol Neurobiol (2016) 0.75
Glutamate Deregulation in Ketamine-Induced Psychosis-A Potential Role of PSD95, NMDA Receptor and PMCA Interaction. Front Cell Neurosci (2017) 0.75
Significance of long chain polyunsaturated fatty acids in human health. Clin Transl Med (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci (2004) 9.73
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05
Pathways towards and away from Alzheimer's disease. Nature (2004) 8.72
Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther (1977) 8.46
The molecular neurobiology of depression. Nature (2008) 6.51
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci (2002) 5.17
Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry (2006) 4.74
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc (2007) 4.51
Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A (1999) 3.82
Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol (2002) 3.62
Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) (1995) 3.61
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci (1997) 3.41
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev (2005) 3.32
Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem (1999) 3.20
Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol (2004) 2.95
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol (2001) 2.88
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci (2004) 2.76
Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav (1986) 2.73
Role of neurotrophic factors in depression. Curr Opin Pharmacol (2006) 2.39
Distinction between preclinical Alzheimer's disease and depression. J Am Geriatr Soc (2000) 2.39
Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry (2006) 2.36
New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev (2008) 2.28
A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev (2001) 2.18
Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry (2004) 2.14
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther (2006) 2.03
Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev (2000) 1.96
Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry (2000) 1.73
Neurotrophins and depression. Trends Pharmacol Sci (1999) 1.70
Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol (2005) 1.58
Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels. Exp Neurol (2007) 1.58
Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci (1995) 1.52
Neurotrophins and activity-dependent plasticity. Prog Brain Res (2000) 1.47
BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol (1999) 1.46
A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry (1997) 1.39
Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci U S A (2006) 1.34
Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport (1996) 1.34
A sensitive open field measure of anxiolytic drug activity. Pharmacol Biochem Behav (1981) 1.23
Depression and the risk of Alzheimer disease. Epidemiology (2005) 1.23
Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry (2008) 1.18
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res (2003) 1.17
Neuropsychiatric symptoms in the dementias. Curr Opin Neurol (2002) 1.13
The expanding role of BDNF: a therapeutic target for Alzheimer's disease? Pharmacogenomics J (2006) 1.11
Elevation in plasma Abeta42 in geriatric depression: a pilot study. Neurochem Res (2006) 1.02
Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav (2008) 1.01
Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease. J Am Geriatr Soc (1987) 0.99
A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem (2002) 0.99
Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J Neurosci (2004) 0.97
Depression in Alzheimer's disease: phenomenology, clinical correlates and treatment. Int Rev Psychiatry (2008) 0.95
Brain-derived neurotrophic factor: a bridge between major depression and Alzheimer's disease? Med Hypotheses (2003) 0.95
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochem Soc Trans (2005) 0.94
Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci (2001) 0.92
State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J Neural Transm (Vienna) (2003) 0.91
The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res (1995) 0.90
Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease. Neuropsychopharmacology (2004) 0.89
Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice. Brain Res (2005) 0.89
Neurotrophins: from pathophysiology to treatment in Alzheimer's disease. Curr Alzheimer Res (2008) 0.88
Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings. Neurobiol Aging (2003) 0.86
Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide. Neuroscience (2007) 0.83
Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens. Neuropsychopharmacology (2007) 0.83
Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression. Exp Neurol (2007) 0.80
Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex. Eur J Pharmacol (1999) 0.79
An ethological analysis of excessive grooming in young and aged rats. Ann N Y Acad Sci (1988) 0.79
Brain-derived neurotrophic factor, serotonin transporter, and depression: comment on Kaufman et al. Biol Psychiatry (2006) 0.78
Serum nerve growth factor concentration and its role in the preclinical stage of dementia. Am J Psychiatry (2002) 0.78
Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neurosci Lett (2002) 0.77
Perinatal cocaine reduces responsiveness to cocaine and causes alterations in exploratory behavior and visual discrimination in young-adult rats. Brain Res (1996) 0.76
Behavioral assessment of norepinephrine and serotonin function and interaction in the hippocampal formation. Pharmacol Biochem Behav (1981) 0.76
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A (2005) 2.96
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
Real-time detection of Helicobacter Pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopy. Endoscopy (2005) 1.97
Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci (2000) 1.92
Senescence and aging: the critical roles of p53. Oncogene (2013) 1.90
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J (1998) 1.86
Functional analysis of the interaction between HCV 5'UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res (1998) 1.72
Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol Aging (1996) 1.59
Reactive oxygen species: from health to disease. Swiss Med Wkly (2012) 1.52
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27
Sequence completion, identification and definition of the fengycin operon in Bacillus subtilis 168. Microbiology (1997) 1.24
Influence of correct secondary and tertiary RNA folding on the binding of cellular factors to the HCV IRES. Nucleic Acids Res (2000) 1.23
Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J (2000) 1.23
Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis (1998) 1.18
Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci (1978) 1.17
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. J Pharmacol Exp Ther (2006) 1.11
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun (1999) 1.08
A 2.6 Mb deletion of 6q24.3-25.1 in a patient with growth failure, cardiac septal defect, thin upperlip and asymmetric dysmorphic ears. Eur J Med Genet (2007) 1.08
Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol (1978) 1.05
Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors. Anticancer Res (1998) 1.03
STAT signalling in the mature and aging brain. Int J Dev Neurosci (2000) 1.01
Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples. Mol Neurobiol (1998) 1.01
Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis (2000) 0.99
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol (2007) 0.98
The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem Pharmacol (2010) 0.98
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia (1994) 0.96
Modulation of rat skeletal muscle chloride channels by activators and inhibitors of protein kinase C. Pflugers Arch (1991) 0.96
Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res (1977) 0.96
The role of anchoring protein RACK1 in PKC activation in the ageing rat brain. Trends Neurosci (1997) 0.96
Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res (1998) 0.96
A defective protein kinase C anchoring system underlying age-associated impairment in TNF-alpha production in rat macrophages. J Immunol (1999) 0.96
Basal ganglia precursors found in aggregates following embryonic transplantation adopt a striatal phenotype in heterotopic locations. Development (1998) 0.93
Multiple penile horns: case report and review. J Urol (1988) 0.93
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum. Neuropharmacology (2006) 0.93
Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci Lett (1995) 0.93
Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR. Curr Pharm Des (2008) 0.92
Classification of calcium antagonists: proposal of the WHO Committee. Pharmacol Res Commun (1987) 0.92
A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutr Metab Cardiovasc Dis (2004) 0.91
Carcinoma in female urethral diverticulum: case reports and review of management. J Urol (1993) 0.90
Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex. J Neurochem (1996) 0.90
Role of endocannabinoids and their analogues in obesity and eating disorders. Eat Weight Disord (2008) 0.90
NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Transl Psychiatry (2012) 0.90
Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur J Neurol (2006) 0.89
In vivo characterization of the mechanisms that secrete enkephalin-like peptides stored in dog adrenal medulla. Neuropharmacology (1981) 0.89
Plasma homocysteine and microvascular complications in type 1 diabetes. Nutr Metab Cardiovasc Dis (2000) 0.89
Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci Lett (1997) 0.89
Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels. J Neurosci Res (2001) 0.88
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2. Neurochem Int (2008) 0.88
Evidence that exposure to methyl mercury during gestation induces behavioral and neurochemical changes in offspring of rats. Neurotoxicol Teratol (1990) 0.88
Detection limits of different approaches in behavioral teratology, and correlation of effects with neurochemical parameters. Neurotoxicol Teratol (1988) 0.88
Behavioural and neurochemical changes in offspring of rats exposed to methyl mercury during gestation. Neurobehav Toxicol Teratol (1984) 0.88
Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. J Neurochem (1985) 0.88
Role of protein kinase Calpha in the regulated secretion of the amyloid precursor protein. Mol Psychiatry (2003) 0.87
Conformationally altered p53: a novel Alzheimer's disease marker? Mol Psychiatry (2007) 0.87
Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine. Psychopharmacology (Berl) (1983) 0.87
Specific role for protein kinase C alpha in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts. Neurosci Lett (1998) 0.86
Ontogenetic and pharmacological dissociation of various components of locomotor activity and habituation in the rat. Int J Dev Neurosci (1988) 0.86
Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol. Psychopharmacology (Berl) (1981) 0.86
Plasma prolactin concentrations in lead exposed workers. J Environ Pathol Toxicol Oncol (1987) 0.86
New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives. J Med Chem (1996) 0.85
Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci Lett (1997) 0.85
In vivo regulation of the release of met-enkephalin-like peptides from dog adrenal medulla. Adv Biochem Psychopharmacol (1982) 0.85
Characterization and distribution of protein kinase C isoforms in human skin fibroblasts. Arch Biochem Biophys (1994) 0.84
Bladder instability: a re-appraisal of classical experimental approaches and development of new therapeutic strategies. J Auton Pharmacol (2002) 0.84
Chronic lead treatment differentially affects dopamine synthesis in various rat brain areas. Toxicology (1979) 0.84
Diagnostic usefulness of apolipoprotein E epsilon 4 in the diagnosis of the dementias. J Neurol Neurosurg Psychiatry (1996) 0.84
Neurotensin effect on dopamine release and calcium transport in rat striatum: interactions with diphenylalkylamine calcium antagonists. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.84
Estrous cycle affects the neurochemical and neurobehavioral profile of carvacrol-treated female rats. Toxicol Appl Pharmacol (2011) 0.84
Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide. Neuroscience (2007) 0.83
Localization of dopamine receptors in the rat cerebral cortex. J Pharm Pharmacol (1976) 0.83
Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. Neurobiol Aging (1998) 0.83
Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? Curr Pharm Des (2010) 0.83
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. Respir Med (2007) 0.82
Recent advances in the pharmacology of Ca2+ and K+ channels. Trends Pharmacol Sci (1995) 0.82
Cytotoxicity of capsaicin in monkey kidney cells: lack of antagonistic effects of capsazepine and Ruthenium red. Arch Toxicol (2000) 0.82
Protein kinase C activity, translocation, and conventional isoforms in aging rat brain. Neurobiol Aging (1995) 0.82
Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int (2000) 0.82
Increase of neurotensin content elicited by neuroleptics in nucleus accumbens. J Pharmacol Exp Ther (1980) 0.82
Mechanisms of the effect of lead on brain neurotransmission: a calcium mediated action. Sci Total Environ (1988) 0.82
Inhibition of prostanoid synthesis protects against neuronal damage induced by focal ischemia in rat brain. Neurosci Lett (1998) 0.81
Specific inhibitory effect of amyloid-beta on presynaptic muscarinic receptor subtypes modulating neurotransmitter release in the rat nucleus accumbens. Neuroscience (2010) 0.81
Effects of chronic ethanol intake at a low dose on the rat brain dopaminergic system. Alcohol (1993) 0.81
Neurofunctional effects of developmental alcohol exposure in alcohol-preferring and alcohol-nonpreferring rats. Neuropsychopharmacology (2001) 0.81
Brain neurotransmitter system and chronic lead intoxication. Pharmacol Res Commun (1980) 0.81
No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer's disease. Minerva Med (2006) 0.81
Oxygen isosteric derivatives of 3-(3-hydroxyphenyl)-N-n-propylpiperidine. J Med Chem (1992) 0.81
Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Exp Neurol (1999) 0.81
Prenatal exposure to a low concentration of carbon monoxide disrupts hippocampal long-term potentiation in rat offspring. J Pharmacol Exp Ther (2000) 0.81
In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes. Br J Cancer (1994) 0.81
PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63. Oncogene (2012) 0.81